Photo of Kristin Madigan

Kristin J. Madigan is a partner in Crowell & Moring’s San Francisco office and a member of the firm’s Litigation and Privacy & Cybersecurity groups. Kristin focuses her practice on representing clients in high-stakes complex litigation with a focus on technology, as well as privacy and consumer protection matters including product counseling, compliance, investigations, enforcement, and litigation that typically involves existing and emerging technologies. In addition, Kristin is well-versed in and counsels clients on California Consumer Privacy Act (CCPA) compliance. Kristin is a Certified Information Privacy Professional/United States (CIPP/US).

The Federal Trade Commission (FTC) was especially active in the consumer protection space this past week, including announcing three separate enforcement actions based on earnings claims and three more for Made in USA claims. On the competition side, the FTC took action against noncompete agreements. These stories and more after the jump.

Continue Reading FTC Blog Updates (April 13 – 17, 2026)

The Federal Trade Commission (FTC) recently released its Strategic Plan for Fiscal Years 2026–2030, setting out the agency’s enforcement priorities and operational objectives for the next five years under Chairman Andrew N. Ferguson. The plan reaffirms the FTC’s commitment to vigorously enforcing the nation’s antitrust and consumer protection laws “without fear or favor.” Critically for

The Federal Trade Commission continued its active enforcement posture in late March 2026, with significant developments spanning healthcare, franchise regulation, competition, and consumer financial protection. The Commission distributed more than $10.9 million to consumers harmed by a credit repair pyramid scheme, while the FTC secured a record-breaking franchise settlement. Chairman Ferguson also launched a new Healthcare Task Force to coordinate agency-wide enforcement efforts in the healthcare sector. These stories and more after the jump.

Continue Reading FTC Updates  (March 16-20, 2026)

In this round of updates, we see updates to several FTC actions related to deceptive marketing as well as several administrative updates.  The FTC has named a deputy director of the bureau of competition and held several workshops on topics of data privacy and security. We also saw several Advance Notices of Proposed Rule Making (ANPRM). These stories and more after the jump.

Continue Reading FTC Updates (January 19 – January 30, 2026)

Wednesday, November 26, 2025

Bureau of Competition; Competition; Nonmerger; Noncompete

  • The FTC finalized a consent order requiring Gateway Services, Inc. and its subsidiary, Gateway US Holdings, Inc. (collectively “Gateway”) to stop entering into or enforcing noncompete agreements on their employees. The order followed the FTC’s September 2025 complaint, which alleged that Gateway’s noncompete agreements were anticompetitive and suppressed competition. Previously, these agreements prohibited Gateway employees from working in the pet cremation industry anywhere in the United States for one year after leaving the company. Under the consent order, Gateway must stop enforcing its existing noncompete agreements and is prohibited from entering into similar agreements in the future.
Continue Reading Updates November 24 – December 5, 2025

Due to the government shutdown, the FTC is closed aside from essential services.  Therefore, Crowell’s FTC updates will resume after the shutdown ends.

The FTC proposed recommendations to rescind and lighten its own regulations. The agency also published its 47th Annual Hart-Scott-Rodino (HSR) Report summarizing merger enforcement actions in 2024. These stories, and more, after the jump.

Continue Reading FTC Updates September 2 – 26, 2025

On July 14, 2025, the FTC announced its enforcement action against telemedicine company NextMed over charges it used misleading prices, fake reviews and deceptive weight-loss claims to sell GLP-1 weight-loss drugs. The FTC has now settled its charges that NextMed used deceptive practices to lure consumers into buying their weight-loss membership programs that had hidden terms and conditions. With the rise of both authentic and counterfeit GLP-1s throughout the nation and the proliferation of the availability of GLP-1s from telemedicine/telehealth companies, online pharmacies and medspas, this announcement is a sign that the federal government will actively monitor these entities to ensure consumers are getting genuine, authentic GLP-1s, that consumers are making informed decisions about weight-loss drugs, and that consumers are not being deceived and duped in the frenzy over GLP-1s.

Continue Reading FTC Uses Its Consumer Protection Powers to Regulate Sellers of GLP-1s

The FTC is heading into summer with an active docket. The agency has been keeping its eye on enforcement, issuing warning letters to contact lens prescribers over potential violations of the agency’s Contact Lens and Eyeglass Rules. Over the next few weeks, it plans on hosting a workshop on healthcare advertising and listening sessions on prescription drug pricing and competition. These stories, and more, after the jump. 

Continue Reading FTC Updates (May 26 – June 16, 2025)

This week, the FTC’s Bureau of Consumer Protection has been busy addressing the “Attention Economy,” false income claims, privacy and data security, and a student debt relief scam. On the competition side, the FTC enforced against raising prices for anesthesiology services. These stories, and more, after the jump.

Continue Reading FTC Blog Updates May 19 – May 23, 2025